IRVINE, Calif., Nov. 19, 2015 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, announced today
that its board of directors approved a two-for-one split of the
company's outstanding shares of common stock to be effected as a
100 percent stock dividend. The company's last stock split
occurred in May 2010; this will be
the company's second stock split since it went public in
April 2000.
Stockholders of record at the close of business on November 30, 2015, will be issued one additional
share of common stock for each share owned as of that date. The
additional shares will be distributed on December 11, 2015. The stock split will increase
the number of common shares outstanding from approximately 108
million shares as of the record date, to approximately 216 million
shares.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of
heart valves and hemodynamic monitoring. Driven by a passion
to help patients, the company partners with clinicians to develop
innovative technologies in the areas of structural heart disease
and critical care monitoring, enabling them to save and enhance
lives. Additional company information can be found at
www.edwards.com.
Edwards, Edwards Lifesciences and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
Logo -
http://photos.prnewswire.com/prnh/20140714/126903
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/edwards-lifesciences-announces-two-for-one-stock-split-300181321.html
SOURCE Edwards Lifesciences Corporation